OncoSec Medical Incorporated Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation (Details Narrative)

Stock-Based Compensation (Details Narrative) - USD ($)						1 Months Ended	3 Months Ended		6 Months Ended
Stock-Based Compensation (Details Narrative) - USD ($)	Oct. 31, 2018	Oct. 29, 2018	Oct. 26, 2018	Oct. 23, 2018	Aug. 22, 2018	Oct. 31, 2018	Oct. 31, 2018	Oct. 31, 2017	Jan. 31, 2018
Number of shares authorized for issuance to awards granted	2,200,176					2,200,176	2,200,176
Purchase price of incentive stock options as a percentage of its fair value							85.00%
Number of stock options cancelled							1,538,541
Options granted to purchase shares							568,500
Term of stock options							1 year 5 months 12 days
Exercise price							$ 1.53
Intrinsic value of options outstanding	$ 2,400,000					$ 2,400,000	$ 2,400,000
Intrinsic value of options exercisable	1,600,000					1,600,000	1,600,000
Unrecognized stock-based compensation expenses	$ 2,800,000					$ 2,800,000	$ 2,800,000
Weighted-average grant date fair value							$ 0.99	$ 0.67
Number of shares issued for service	82,000
Restricted Stock Units (RSUs) [Member]
Stock-based compensation expense recognized							$ 150,000	$ 100,000
Options granted to purchase shares						50,000
Exercise price						$ 1.64
Number of granted shares vested		12,500	25,000			37,500
Number of shares vesting percentage			25.00%
Number of shares vesting, description			The Company's Board of Directors approved the accelerated vesting of 25% of the outstanding restricted stock units (RSUs) held by the employee. The RSUs, which originally vest on the third anniversary of the grant date, or March 29, 2020, were accelerated to vest on October 26, 2018.
Modification of accrued expense on unvested stock units			$ 63,278
Fair value of vested stock grants			$ 44,250
Number of restricted stock outstanding	518,020					518,020	518,020
Restricted Stock Units (RSUs) [Member] \| October 29, 2019 [Member]
Number of granted shares vested						12,500
Restricted Stock Units (RSUs) [Member] \| October 29, 2020 [Member]
Number of granted shares vested						12,500
Restricted Stock Units (RSUs) [Member] \| October 29, 2021 [Member]
Number of granted shares vested						12,500
Research And Development Expense [Member]
Stock-based compensation expense recognized							$ 738,000	200,000
General And Administrative Expense [Member]
Stock-based compensation expense recognized							$ 527,000	$ 400,000
Maximum [Member]
Maturity							6 years 6 months	6 years 6 months
Minimum [Member]
Maturity							5 years	5 years
Individual [Member] \| Stock Option Cancellation Agreement [Member]
Number of vested stock options cancelled					300,000
Number of restricted stock issued					175,000
Stock-based compensation expense recognized					$ 135,425
Two Consultants [Member] \| Stock Option Cancellation Agreement [Member]
Stock-based compensation expense recognized				$ 377,278
Number of stock options cancelled				535,000
Employees [Member]
Options granted to purchase shares							200,000
Term of stock options							10 years
Vesting period							3 years
Exercise price							$ 1.64
Consultants [Member]
Stock-based compensation expense recognized							$ 239,824	$ 109,000
Options granted to purchase shares							250,000
Term of stock options							10 years
Exercise price							$ 1.43
Number of shares issued for service							184,000	100,000
Number of shares issued for service, value							$ 251,560	$ 109,000
Employees, Directors and Consultants [Member]
Stock-based compensation expense recognized							$ 1,300,000	$ 600,000
2011 Plan [Member]
Number of shares authorized for issuance to awards granted	1,000,000					1,000,000	1,000,000
Maximum shares granted per fiscal year per individual							8,500,000
2011 Plan [Member] \| Minimum [Member]
Purchase price of incentive stock options as a percentage of its fair value							100.00%
Provisional percentage of outstanding stock owned by stockholders							10.00%
Exercise price as a percentage of fair value of common stock							110.00%
2011 Plan [Member] \| Common Stock [Member] \| Maximum [Member]
Maximum shares granted per fiscal year per individual							500,000
Stock option exercisable period							10 years
2011 Plan [Member] \| Employee, Director and Consultants [Member]
Employee stock purchase program description							The 2011 Plan authorizes a total of 7,500,000 for issuance thereunder, and includes an automatic increase of the number of shares of common stock reserved thereunder on the first business day of each calendar year by the lesser of: (i) 3% of the shares of the Company's common stock outstanding as of the last day of the immediately preceding calendar year; (ii) 1,000,000 shares; or (iii) such lesser number of shares as determined by the Company's Board of Directors.
Number of shares authorized for issuance to awards granted	7,500,000					7,500,000	7,500,000
2011 Plan [Member] \| Employees [Member]
Options granted to purchase shares							111,000	163,500
Term of stock options							10 years	10 years
Vesting period							3 years	3 years
2011 Plan [Member] \| Employees [Member] \| Maximum [Member]
Exercise price							$ 1.58	$ 0.96
2011 Plan [Member] \| Employees [Member] \| Minimum [Member]
Exercise price							$ 1.32	$ 0.92
2011 Plan [Member] \| Consultants [Member]
Options granted to purchase shares								50,000
Term of stock options								10 years
Exercise price								$ 1.00
2011 Plan [Member] \| Directors [Member]
Options granted to purchase shares								200,000
Term of stock options								10 years
Vesting period								1 year
2011 Plan [Member] \| Directors [Member] \| Maximum [Member]
Exercise price								$ 1.08
2011 Plan [Member] \| Directors [Member] \| Minimum [Member]
Exercise price								$ 0.979
ESPP [Member]
Number of shares authorized for issuance to awards granted	410,903					410,903	410,903
Purchase price of incentive stock options as a percentage of its fair value							85.00%
Stock-based compensation expense recognized							$ 6,600	$ 7,000
Stock issued during period, shares, employee stock purchase plans							500,000
Discount from market price, offering date							15.00%
Fair market value of unvested shares, percentage							15.00%
ESPP [Member] \| Black-Scholes Option Valuation Model [Member]
Maturity									6 months
Risk free interest rate									1.15%
Volatility rate									62.60%
Forfeitures percentage									0.00%
Dividend									$ 0
ESPP [Member] \| January 31, 2019 [Member] \| Black-Scholes Option Valuation Model [Member]
Maturity							6 months
Risk free interest rate							2.22%
Volatility rate							61.83%
Forfeitures percentage							0.00%
Dividend							$ 0
ESPP [Member] \| July 31, 2016 [Member] \| First Offering Period [Member]
Shares purchased							17,789
ESPP [Member] \| January 31, 2017 [Member] \| Second Offering Period [Member]
Shares purchased							18,631
ESPP [Member] \| July 31, 2017 [Member] \| Third Offering Period [Member]
Shares purchased							21,646
ESPP [Member] \| January 31, 2018 [Member] \| Fourth Offering Period [Member]
Shares purchased							18,960
ESPP [Member] \| July 31, 2018 [Member] \| Fifth Offering Period [Member]
Shares purchased							12,071